Cat omega interferon mutant as well as preparation method and application thereof

A technology of interferon and mutant, which can be used in the preparation of medicines or reagents for preventing or treating feline viral diseases, the preparation and application of cat ω interferon, and the field of cat ω interferon mutants, which can solve the problem of weak antiviral activity, The problem of low expression of cat interferon

Active Publication Date: 2015-07-22
THE INST OF BIOTECHNOLOGY OF THE CHINESE ACAD OF AGRI SCI
View PDF3 Cites 21 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no specific drug for the treatment of viral diseases, and there is an urgent need for high-quality and cheap feline interferon products to be launched, but the expression level of feline interferon is not high at present, and the antiviral activity is not strong

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cat omega interferon mutant as well as preparation method and application thereof
  • Cat omega interferon mutant as well as preparation method and application thereof
  • Cat omega interferon mutant as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0049] Embodiment 1 Expression and detection of feline interferon ω2, 9, 11 and ω2 mutant gene sequence in silkworm bioreactor

[0050] 1. Experimental method

[0051] 1.1 Acquisition, synthesis and plasmid construction of feline ω-type interferon gene

[0052] 1.1.1 Acquisition of genes

[0053] Search and obtain the gene sequence and amino acid sequence of FeIFN-ω2 (GenBank accession number: DQ420221), FeIFN-ω9 (GenBank accession number: DQ420228), FeIFN-ω11 (GenBank accession number: DQ420230.1) from NCBI.

[0054] Among them, the amino acid sequence of feline ω2 interferon is shown in SEQ ID NO.1, its gene sequence is shown in SEQ ID NO.3; the amino acid sequence of cat ω11 interferon is shown in SEQ ID NO.6.

[0055] After comparing the gene sequences and amino acid sequences of the 13 subtypes of feline ω-interferon, it was found that the amino acid composition of each subtype has very small mutations, such as amino acid changes from P to L, and G to A; cat ω-interfero...

Embodiment 2

[0073] Example 2 Expression and detection of mutated and optimized feline interferon ω11 gene in silkworm bioreactor

[0074] Based on the comparison results of Example 1, the mutation of the cat ω2 interferon gene is beneficial to the improvement of antiviral activity. Therefore, the cat ω11 type interferon gene was mutated according to the same method as ω2-M.

[0075] 1. Experimental method

[0076]1.1 Mutation, optimization and synthesis of feline ω11-type interferon gene

[0077] Obtain the gene sequence and amino acid sequence of FeIFN-ω11 (GenBank accession number: DQ420230.1) from NCBI, according to the method of Example 1, introduce 4 amino acid site-directed mutations: R82Q, P105L, V141A, G194A, and obtain 196 The amino acid mutant sequence is shown in SEQ ID NO.7, and the deduced mutant gene sequence is shown in SEQ ID NO.8. The DNAman software was used to analyze the restriction enzyme cutting sites of the mutated gene sequence. According to the analysis results ...

Embodiment 3

[0097] Embodiment 3 Mutation and optimization of cat interferon ω2 gene and expression and detection in silkworm bioreactor

[0098] Based on the results of Examples 1 and 2, cat ω-interferon gene mutation and optimization are conducive to the improvement of antiviral activity. For this reason, cat ω-2 type interferon gene and mutant gene are adjusted to ω2 and ω2-M according to the optimization method in Example 2. Gene optimization, the specific method is as follows:

[0099] 1. Experimental method

[0100] 1.1 Construction of cat ω2 interferon mutant gene and optimization and synthesis of ω2 interferon gene and mutant gene sequence

[0101] 1.1.1 Construction of cat ω2-type interferon mutant gene

[0102] The present invention is based on the comparison results of the gene sequences and amino acid sequences of 13 subtypes of feline ω-interferon in Example 1. In order to improve the expression of feline ω-interferon in the baculovirus expression system, the present inventi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a cat omega interferon mutant as well as a preparation method and an application thereof, and belongs to the field of preparation and application of cat omega interferons. A cat omega 2 or omega 11 interferon mutant is obtained by comparing gene sequences and amino acid sequences of 13 subtypes of cat omega interferon and performing amino acid site-directed mutation on cat omega 2 or omega 11 interferon. The invention further discloses the method for preparing the cat omega interferon mutant. The method comprises the following steps: cloning a gene for coding the cat omega 2 or omega 11 interferon mutant into a baculovirus transfer vector, recombining with a baculovirus for infecting an insect host, expressing an exogenous gene, and obtaining a cat omega interferon protein expression product. The method is simple in process, the cat omega interferon capable of being safe to use can be efficiently and stably obtained, and the antiviral activity of the cat omega interferon mutant is remarkably improved. The cat omega 2 or omega 11 interferon mutant can be used for preparing drugs or reagents for preventing or treating cat viral diseases.

Description

technical field [0001] The present invention relates to feline ω interferon, in particular to a cat ω interferon mutant, and the present invention also relates to a preparation method of the feline ω interferon mutant and its use in the preparation of drugs or reagents for preventing or treating feline viral diseases The invention belongs to the field of preparation and application of feline omega interferon. Background technique [0002] Interferon (IFN) is a highly biologically active glycoprotein produced by cells under the action of specific inducers, and has broad-spectrum antiviral activity in animal cells. It is currently known that interferon does not directly kill the virus, but interferes with the gene transcription of the virus or the translation of viral protein components by inducing the host's own cells to produce a variety of enzymes. Interferon can be divided into type I and type II IFN according to different cell sources, physical and chemical properties an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K14/555C12N15/20C12N15/866A61K38/21A61P31/20A61P31/14A61P31/18
CPCA61K38/00C07K14/555C12N15/866
Inventor 胡小元李轶女张志芳李浩洋刘兴键易咏竹陈晓妍
Owner THE INST OF BIOTECHNOLOGY OF THE CHINESE ACAD OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap